Major Rugby Recalls Levothyroxine Sodium Tablets Nationwide Due to Subpotency

Major Rugby has issued a nationwide recall of 12 levothyroxine sodium tablet products across the United States. Tests revealed that the common thyroid medication may contain a lower dose of the active ingredient than intended, rendering it subpotent. Patients are advised to check lot numbers, stop using affected batches, and consult their healthcare providers. While serious adverse health effects are not expected, the reduced potency could impact long-term thyroid hormone replacement.